Primary decision context: Choosing between two magnesium forms without equating elemental content or marketing claims with clinical superiority.
Quick verdict
No profile-level evidence winner
Both canonical records currently carry the same profile-level evidence grade (D). The useful decision therefore depends on outcome-specific human evidence, dose, formulation, and safety rather than the overall grade alone.
Magnesium glycinate and magnesium oxide differ in formulation and may differ in practical dose and tolerability context. This comparison keeps the decision anchored to the evidence and safety data actually present for each form.
The table below is populated from each ingredient’s canonical runtime record. Missing fields stay visibly missing rather than being filled with mechanism-derived assumptions.
Choose Magnesium Glycinate if…
•Its human-evidence summary directly addresses the outcome you are researching.
•Its studied dose and formulation context match the form you are actually evaluating.
•You have reviewed its documented safety and interaction constraints rather than choosing on marketing claims alone.
Choose Magnesium Oxide if…
•Its human-evidence summary directly addresses the outcome you are researching.
•Its studied dose and formulation context match the form you are actually evaluating.
•You have reviewed its documented safety and interaction constraints rather than choosing on marketing claims alone.
Neither may be appropriate if…
The comparison itself does not clear the decision bar
•Neither option has adequate human outcome evidence for the actual decision context: Choosing between two magnesium forms without equating elemental content or marketing claims with clinical superiority.
•The available comparison is driven mainly by mechanism, chemistry, or marketing rather than replicated human outcomes.
•A contraindication, medication interaction, pregnancy concern, or other safety constraint makes unsupervised use inappropriate.
•The relevant studied formulation or dose is materially different from the product or form being considered.
Magnesium Glycinate vs Magnesium Oxide: evidence, dose, and safety
This table scrolls horizontally on small screens. Use Tab to focus the table region, then scroll with arrow keys or touch.
Magnesium Glycinate vs Magnesium Oxide: evidence, dose, and safety
Dimension
Magnesium Glycinate
Magnesium Oxide
Evidence strength
D
D
Human evidence
Not available in the canonical record.
Not available in the canonical record.
Studied dose / dose context
chelated mineral capsule or powder
chelated mineral capsule or powder
Forms / preparation
Not available in the canonical record.
Not available in the canonical record.
Safety
Safety evidence: magnesium supplements can cause dose-related gastrointestinal effects. Severe renal impairment increases hypermagnesemia risk, and magnesium can reduce absorption of some oral antibiotics and bisphosphonates; glycinate-specific comparative safety evidence remains limited.
Safety evidence: magnesium oxide commonly has dose-related gastrointestinal and laxative effects. Severe renal impairment increases hypermagnesemia risk, and magnesium can reduce absorption of some oral antibiotics and bisphosphonates; use medication-specific separation guidance.
Safety evidence: magnesium supplements can cause dose-related gastrointestinal effects. Severe renal impairment increases hypermagnesemia risk, and magnesium can reduce absorption of some oral antibiotics and bisphosphonates; glycinate-specific comparative safety evidence remains limited.
Magnesium Oxide
Safety evidence: magnesium oxide commonly has dose-related gastrointestinal and laxative effects. Severe renal impairment increases hypermagnesemia risk, and magnesium can reduce absorption of some oral antibiotics and bisphosphonates; use medication-specific separation guidance.
Magnesium oxide has lower bioavailability compared to other forms.
Read the full profile →Mechanism differences are shown as mechanism context, not as proof of different health benefits. Comparison conclusions should follow human outcome evidence, safety, dose, and formulation data where those fields are available.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.